These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23185821)

  • 1. [Pharmacovigilance].
    Livio F; Renard D; Buclin T
    Rev Med Suisse; 2012 Jan; 8(324):116-9. PubMed ID: 23185821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacovigilance update].
    Livio F; Biollaz J; Buclin T
    Rev Med Suisse; 2011 Jan; 7(277):71-4. PubMed ID: 21309181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Introduction of pharmacovigilance in a new university hospital in Morocco: how and why].
    Khabbal Y; Alami L; Nejjari C
    East Mediterr Health J; 2012 Jun; 18(6):648-52. PubMed ID: 22888624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of reports on "pregnancy and drugs" received during a period of 39 months by the Regional Pharmacovigilance Center, Lorraine (Nancy)].
    Hanesse B; Trechot P; el Kouch S; Pierfitte C; Royer R; Netter P
    Therapie; 1995; 50(5):471-2. PubMed ID: 8571291
    [No Abstract]   [Full Text] [Related]  

  • 8. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.
    Théophile H; André M; Arimone Y; Haramburu F; Miremont-Salamé G; Bégaud B
    J Clin Epidemiol; 2012 Oct; 65(10):1069-77. PubMed ID: 22910538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of the 22nd French pharmacovigilance meeting.
    Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug vigilance: opinion survey among residents of a university hospital].
    Graille V; Lapeyre-Mestre M; Montastruc JL
    Therapie; 1994; 49(5):451-4. PubMed ID: 7855763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital].
    Guédat MG; Gouraud A; Ramiah T; Demazière J; Delanoy B; Vial T; Leboucher G; Charpiat B
    Therapie; 2012; 67(3):243-50. PubMed ID: 22874491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance and teratovigilance].
    Livio F; Buclin T; Biollaz J
    Rev Med Suisse; 2007 Jan; 3(95):238-42. PubMed ID: 17357693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center'].
    Lemoine T; Lacroix I; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Therapie; 2001; 56(3):287-93. PubMed ID: 11475810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reaction monitoring in Jena--experiences of a regionalized pharmacovigilance centre.
    Hoffmann A; Hippius M; Sicker T
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):453-7. PubMed ID: 9784022
    [No Abstract]   [Full Text] [Related]  

  • 16. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.
    Ehrenpreis ED; Sifuentes H; Ehrenpreis JE; Smith ZL; Marshall ML
    Expert Opin Drug Saf; 2012 Mar; 11(2):177-83. PubMed ID: 22316142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
    Mazé F; Bégaud B
    Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs: watch out for unexpected adverse effects.
    Prescrire Int; 2002 Oct; 11(61):150-1. PubMed ID: 12378747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric pharmacovigilance.
    Prescrire Int; 2002 Dec; 11(62):183. PubMed ID: 12472099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.